Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Bertelsen, Bent
DOB:	12-SEP-1942 (Age: 83)
Gender:	male
Address:	Bygget 41 340 14 Lagan (Sweden)
ID:	9943-935126-5

Report
Date:	04-MAY-2024

Laboratory

Requested by
Värnamo sjukhus 331 56 Värnamo (Sweden)

Specimen
Collected:	03-MAY-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	03 May 2024	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.9	4.5 - 6.4	%
Glucose [Mass/volume] in Blood	83.1	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	13.2	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.6 L	0.8 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.2	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.9	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.2	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	103.0	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	21.8 L	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	201.1 H	0 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	120.2	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	144.3 H	70 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	32.8 L	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows stable glucose control (HbA1c and glucose within or near target), normal renal function (urea nitrogen normal, creatinine slightly low but not clinically concerning), and normal electrolytes. Lipid profile reveals mildly elevated total and LDL cholesterol, and low HDL, indicating increased cardiovascular risk. Mildly low CO₂ may suggest a tendency toward mild metabolic acidosis but is not severe. Overall, results are mostly stable; recommend lipid management and continued monitoring.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows stable glucose control (HbA1c and glucose within or near target), normal renal function (urea nitrogen normal, creatinine slightly low but not clinically concerning), and normal electrolytes. Lipid profile reveals mildly elevated total and LDL cholesterol, and low HDL, indicating increased cardiovascular risk. Mildly low CO₂ may suggest a tendency toward mild metabolic acidosis but is not severe. Overall, results are mostly stable; recommend lipid management and continued monitoring.